Back to search

France· FR:64779557

BIAFINEACT, émulsion pour application cutanée

A trolamine product containing trolamine, registered in France by KENVUE FRANCE. The same ATC class is registered in 2 of our 19 countries.

ATC D03AX12

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedBIAFINEACT, émulsion pour application…ATCD03AX12REGISTER NO.FR:64779557PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Trolamine is registered in 2 of 19 countries.

Countries holding a registration under ATC D03AX12 (trolamine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 1 of them publish a price we can compare per daily dose

Trolamine · ATC D03AX12

2 / 19 countries

  • Franceprice
  • Germany
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
TROLAMINE
Manufacturer
KENVUE FRANCE
Country
France (FR)
ATC code
D03AX12
ATC class
Trolamine
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400937832090
    1 tube(s) aluminium verni de 139,5 g

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Trolamine in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trolamine products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Germany · Triethanolamin Smartpractice Europe
  • Luxembourg · Biafine
  • Malta · Biafine
  • Portugal · Biafine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/21e94933-a39e-4c5f-8abf-f36172ed074f
GET /v1/drugs/21e94933-a39e-4c5f-8abf-f36172ed074f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "64779557",
  "date_amm": "2007-01-24",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "TROLAMINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "émulsion pour application",
  "voies_administration": "cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about trolamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.